_id
6919e8383c536f8df231823e
Ticker
FUM.LSE
Name
Futura Medical
Exchange
LSE
Address
Surrey Technology Centre, Guildford, United Kingdom, GU2 7YG
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://www.futuramedical.com
Description
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Last Close
11000
Volume
2163162
Current Price
1.28
Change
4.545454545454529
Last Updated
2025-12-30T10:56:32.571Z
Image
https://logo.clearbit.com/www.futuramedical.com
Ipo Date
-
Market Cap
6392327
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1001154
Cost Of Revenue
758036
Gross Profit
243118
Operating Expenses
6967273
Operating Income
-6724155
Interest Expense
-
Pretax Income
-6685965
Net Income
-6585965
Eps
-0.021677149068871974
Dividends Per Share
-
Shares Outstanding
581120659
Income Tax Expense
-100000
EBITDA
-6623963
Operating Margin
-671.6404269473028
Total Other Income Expense Net
38190
Cash
3689549
Short Term Investments
-
Receivables
856959
Inventories
33710
Total Current Assets
4680218
Property Plant Equipment
807605
Total Assets
5487823
Payables
796351
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2441020
Equity
3046803
Bs_currency_symbol
GBP
Depreciation
62000
Change In Working Capital
-662626
Cash From Operations
-2940829
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
34177
Net Change In Cash
-2906652
Cf_currency_symbol
-
PE
-
PB
127.63884021382412
ROE
-216.15985674164034
ROA
-120.01052147636686
FCF
-2940829
Fcf Percent
-2.9374391951687753
Piotroski FScore
1
Health Score
23
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1001154
Quarters > 0 > income Statement > cost Of Revenue
758036
Quarters > 0 > income Statement > gross Profit
243118
Quarters > 0 > income Statement > operating Expenses
6967273
Quarters > 0 > income Statement > operating Income
-6724155
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-6685965
Quarters > 0 > income Statement > net Income
-6585965
Quarters > 0 > income Statement > eps
-0.021677149068871974
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
303820626
Quarters > 0 > income Statement > income Tax Expense
-100000
Quarters > 0 > income Statement > EBITDA
-6623963
Quarters > 0 > income Statement > operating Margin
-671.6404269473028
Quarters > 0 > income Statement > total Other Income Expense Net
38190
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3689549
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
856959
Quarters > 0 > balance Sheet > inventories
33710
Quarters > 0 > balance Sheet > total Current Assets
4680218
Quarters > 0 > balance Sheet > property Plant Equipment
807605
Quarters > 0 > balance Sheet > total Assets
5487823
Quarters > 0 > balance Sheet > payables
796351
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2441020
Quarters > 0 > balance Sheet > equity
3046803
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-6585965
Quarters > 0 > cash Flow > depreciation
62000
Quarters > 0 > cash Flow > change In Working Capital
-662626
Quarters > 0 > cash Flow > cash From Operations
-2940829
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
34177
Quarters > 0 > cash Flow > net Change In Cash
-2906652
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.021677149068871974
Quarters > 0 > ratios > PB
127.63884021382412
Quarters > 0 > ratios > ROE
-216.15985674164034
Quarters > 0 > ratios > ROA
-120.01052147636686
Quarters > 0 > ratios > FCF
-2940829
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.9374391951687753
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
6925429
Quarters > 1 > income Statement > cost Of Revenue
2119186
Quarters > 1 > income Statement > gross Profit
4806243
Quarters > 1 > income Statement > operating Expenses
4450258
Quarters > 1 > income Statement > operating Income
296593
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
424204
Quarters > 1 > income Statement > net Income
291369
Quarters > 1 > income Statement > eps
0.001
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
291369000
Quarters > 1 > income Statement > income Tax Expense
132835
Quarters > 1 > income Statement > EBITDA
486624
Quarters > 1 > income Statement > operating Margin
4.282666099096533
Quarters > 1 > income Statement > total Other Income Expense Net
127611
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
6596201
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2448465
Quarters > 1 > balance Sheet > inventories
455906
Quarters > 1 > balance Sheet > total Current Assets
9500572
Quarters > 1 > balance Sheet > property Plant Equipment
4089607
Quarters > 1 > balance Sheet > total Assets
13590179
Quarters > 1 > balance Sheet > payables
1493238
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4627348
Quarters > 1 > balance Sheet > equity
8962831
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
291369
Quarters > 1 > cash Flow > depreciation
62421
Quarters > 1 > cash Flow > change In Working Capital
1861458
Quarters > 1 > cash Flow > cash From Operations
3442260
Quarters > 1 > cash Flow > capital Expenditures
903730
Quarters > 1 > cash Flow > cash From Investing
-903732
Quarters > 1 > cash Flow > cash From Financing
147681
Quarters > 1 > cash Flow > net Change In Cash
2675875
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.001
Quarters > 1 > ratios > PB
41.61099545444961
Quarters > 1 > ratios > ROE
3.250859019878875
Quarters > 1 > ratios > ROA
2.143967345831133
Quarters > 1 > ratios > FCF
2538530
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.36655202154263655
Quarters > 1 > health Score
62
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
7000693
Quarters > 2 > income Statement > cost Of Revenue
2239434
Quarters > 2 > income Statement > gross Profit
4761259
Quarters > 2 > income Statement > operating Expenses
3941557
Quarters > 2 > income Statement > operating Income
819702
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
866641
Quarters > 2 > income Statement > net Income
1001641
Quarters > 2 > income Statement > eps
0.003155403339618302
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
317436756
Quarters > 2 > income Statement > income Tax Expense
-135000
Quarters > 2 > income Statement > EBITDA
926052
Quarters > 2 > income Statement > operating Margin
11.70886939335863
Quarters > 2 > income Statement > total Other Income Expense Net
46939
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
3920326
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2088034
Quarters > 2 > balance Sheet > inventories
140
Quarters > 2 > balance Sheet > total Current Assets
6218011
Quarters > 2 > balance Sheet > property Plant Equipment
3248057
Quarters > 2 > balance Sheet > total Assets
9466068
Quarters > 2 > balance Sheet > payables
404067
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1657291
Quarters > 2 > balance Sheet > equity
7808777
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
1001641
Quarters > 2 > cash Flow > depreciation
59411
Quarters > 2 > cash Flow > change In Working Capital
-5237501
Quarters > 2 > cash Flow > cash From Operations
-3003849
Quarters > 2 > cash Flow > capital Expenditures
823231
Quarters > 2 > cash Flow > cash From Investing
-823233
Quarters > 2 > cash Flow > cash From Financing
23230
Quarters > 2 > cash Flow > net Change In Cash
-3789674
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.003155403339618302
Quarters > 2 > ratios > PB
52.03363441932072
Quarters > 2 > ratios > ROE
12.827117485875188
Quarters > 2 > ratios > ROA
10.581383949492016
Quarters > 2 > ratios > FCF
-3827080
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-0.5466715937979283
Quarters > 2 > health Score
61
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
1397521
Quarters > 3 > income Statement > cost Of Revenue
532357
Quarters > 3 > income Statement > gross Profit
865164
Quarters > 3 > income Statement > operating Expenses
5869862
Quarters > 3 > income Statement > operating Income
-5004700
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-4750928
Quarters > 3 > income Statement > eps
-0.016273462434209823
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
291943280
Quarters > 3 > income Statement > income Tax Expense
4750928
Quarters > 3 > income Statement > EBITDA
-4939708
Quarters > 3 > income Statement > operating Margin
-358.112686678769
Quarters > 3 > income Statement > total Other Income Expense Net
5004700
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
7714182
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1147709
Quarters > 3 > balance Sheet > inventories
339
Quarters > 3 > balance Sheet > total Current Assets
9331605
Quarters > 3 > balance Sheet > property Plant Equipment
2484748
Quarters > 3 > balance Sheet > total Assets
11816353
Quarters > 3 > balance Sheet > payables
1006054
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6339534
Quarters > 3 > balance Sheet > equity
5476819
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-4753827
Quarters > 3 > cash Flow > depreciation
64990
Quarters > 3 > cash Flow > change In Working Capital
3974869
Quarters > 3 > cash Flow > cash From Operations
1229168
Quarters > 3 > cash Flow > capital Expenditures
1498968
Quarters > 3 > cash Flow > cash From Investing
-1498963
Quarters > 3 > cash Flow > cash From Financing
143087
Quarters > 3 > cash Flow > net Change In Cash
-124707
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
-0.016273462434209823
Quarters > 3 > ratios > PB
68.2307372947691
Quarters > 3 > ratios > ROE
-86.74612033006751
Quarters > 3 > ratios > ROA
-40.20638178294098
Quarters > 3 > ratios > FCF
-269800
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.1930561329668749
Quarters > 3 > health Score
18
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
13926122
Annuals > 0 > income Statement > cost Of Revenue
4236788
Annuals > 0 > income Statement > gross Profit
9567502
Annuals > 0 > income Statement > operating Expenses
8391815
Annuals > 0 > income Statement > operating Income
1175687
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
1290845
Annuals > 0 > income Statement > net Income
1293010
Annuals > 0 > income Statement > eps
0.004160695380232552
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
310767764
Annuals > 0 > income Statement > income Tax Expense
-2165
Annuals > 0 > income Statement > EBITDA
1412678
Annuals > 0 > income Statement > operating Margin
8.442314378690636
Annuals > 0 > income Statement > total Other Income Expense Net
115158
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
6596201
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2448465
Annuals > 0 > balance Sheet > inventories
455906
Annuals > 0 > balance Sheet > total Current Assets
9500572
Annuals > 0 > balance Sheet > property Plant Equipment
4089607
Annuals > 0 > balance Sheet > total Assets
13590179
Annuals > 0 > balance Sheet > payables
1493238
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4627348
Annuals > 0 > balance Sheet > equity
8962831
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
1293010
Annuals > 0 > cash Flow > depreciation
121832
Annuals > 0 > cash Flow > change In Working Capital
-3376043
Annuals > 0 > cash Flow > cash From Operations
438411
Annuals > 0 > cash Flow > capital Expenditures
1726961
Annuals > 0 > cash Flow > cash From Investing
-1726965
Annuals > 0 > cash Flow > cash From Financing
170911
Annuals > 0 > cash Flow > net Change In Cash
-1117981
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
0.004160695380232552
Annuals > 0 > ratios > PB
38.10556872443539
Annuals > 0 > ratios > ROE
14.42635702938056
Annuals > 0 > ratios > ROA
9.5142970523052
Annuals > 0 > ratios > FCF
-1288550
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.09252755361471054
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
3100968
Annuals > 1 > income Statement > cost Of Revenue
1326743
Annuals > 1 > income Statement > gross Profit
1774225
Annuals > 1 > income Statement > operating Expenses
8737995
Annuals > 1 > income Statement > operating Income
-6963770
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-6891973
Annuals > 1 > income Statement > net Income
-6512899
Annuals > 1 > income Statement > eps
-0.021608395587412923
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
301405950
Annuals > 1 > income Statement > income Tax Expense
-379074
Annuals > 1 > income Statement > EBITDA
-6833498
Annuals > 1 > income Statement > operating Margin
-224.56761888545768
Annuals > 1 > income Statement > total Other Income Expense Net
71797
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
7714182
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1147709
Annuals > 1 > balance Sheet > inventories
339
Annuals > 1 > balance Sheet > total Current Assets
9331605
Annuals > 1 > balance Sheet > property Plant Equipment
2484748
Annuals > 1 > balance Sheet > total Assets
11816353
Annuals > 1 > balance Sheet > payables
1006054
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6339534
Annuals > 1 > balance Sheet > equity
5476819
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-6891973
Annuals > 1 > cash Flow > depreciation
130272
Annuals > 1 > cash Flow > change In Working Capital
3611595
Annuals > 1 > cash Flow > cash From Operations
570253
Annuals > 1 > cash Flow > capital Expenditures
1505850
Annuals > 1 > cash Flow > cash From Investing
-1434052
Annuals > 1 > cash Flow > cash From Financing
4549868
Annuals > 1 > cash Flow > net Change In Cash
3688070
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.021608395587412923
Annuals > 1 > ratios > PB
60.48130110744941
Annuals > 1 > ratios > ROE
-118.91755049783458
Annuals > 1 > ratios > ROA
-55.11767463277375
Annuals > 1 > ratios > FCF
-935597
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.3017112720931012
Annuals > 1 > health Score
18
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
24734
Annuals > 2 > income Statement > gross Profit
-24734
Annuals > 2 > income Statement > operating Expenses
6871489
Annuals > 2 > income Statement > operating Income
-6871489
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-6871489
Annuals > 2 > income Statement > net Income
-5846495
Annuals > 2 > income Statement > eps
-0.020337187128944504
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
287478055
Annuals > 2 > income Statement > income Tax Expense
-1024994
Annuals > 2 > income Statement > EBITDA
-6846757
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-99509
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
4026112
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1092945
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
5314627
Annuals > 2 > balance Sheet > property Plant Equipment
1158035
Annuals > 2 > balance Sheet > total Assets
6472662
Annuals > 2 > balance Sheet > payables
316181
Annuals > 2 > balance Sheet > short Term Debt
432151
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1753109
Annuals > 2 > balance Sheet > equity
4719553
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-6871489
Annuals > 2 > cash Flow > depreciation
24734
Annuals > 2 > cash Flow > change In Working Capital
-511504
Annuals > 2 > cash Flow > cash From Operations
-5775346
Annuals > 2 > cash Flow > capital Expenditures
740697
Annuals > 2 > cash Flow > cash From Investing
-740697
Annuals > 2 > cash Flow > cash From Financing
169584
Annuals > 2 > cash Flow > net Change In Cash
-6346459
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.020337187128944504
Annuals > 2 > ratios > PB
66.9424376514047
Annuals > 2 > ratios > ROE
-123.87815117236738
Annuals > 2 > ratios > ROA
-90.32597407372732
Annuals > 2 > ratios > FCF
-6516043
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
26
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
19808
Annuals > 3 > income Statement > gross Profit
-19808
Annuals > 3 > income Statement > operating Expenses
5866311
Annuals > 3 > income Statement > operating Income
-5866311
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-5866311
Annuals > 3 > income Statement > net Income
-4957711
Annuals > 3 > income Statement > eps
-0.01829101970111152
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
271046179
Annuals > 3 > income Statement > income Tax Expense
-908600
Annuals > 3 > income Statement > EBITDA
-5846502
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
39539
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
10372571
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
915859
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
11360139
Annuals > 3 > balance Sheet > property Plant Equipment
442657
Annuals > 3 > balance Sheet > total Assets
11802796
Annuals > 3 > balance Sheet > payables
981392
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2078184
Annuals > 3 > balance Sheet > equity
9724612
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-5866311
Annuals > 3 > cash Flow > depreciation
19808
Annuals > 3 > cash Flow > change In Working Capital
1272193
Annuals > 3 > cash Flow > cash From Operations
-3873270
Annuals > 3 > cash Flow > capital Expenditures
419722
Annuals > 3 > cash Flow > cash From Investing
-419722
Annuals > 3 > cash Flow > cash From Financing
13646962
Annuals > 3 > cash Flow > net Change In Cash
9353970
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.01829101970111152
Annuals > 3 > ratios > PB
30.63153066888427
Annuals > 3 > ratios > ROE
-50.981067419450774
Annuals > 3 > ratios > ROA
-42.00454705817164
Annuals > 3 > ratios > FCF
-4292992
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
26
Valuation > metrics > PE
-0.021677149068871974
Valuation > metrics > PB
127.63884021382412
Valuation > final Score
20
Valuation > verdict
4154.6% Overvalued
Profitability > metrics > ROE
-216.15985674164034
Profitability > metrics > ROA
-140.71919299485623
Profitability > metrics > Net Margin
-6.57837355691532
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8011742144142565
Risk > metrics > Interest Coverage
-108.45061449630657
Risk > final Score
-386
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.8770793280852285
Liquidity > metrics > Quick Ratio
5.8347487477255635
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
22
Prev Profitabilities > 1
77
Prev Profitabilities > 2
0
Prev Risks > 0
67
Prev Risks > 1
100
Prev Risks > 2
26
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:01:33.007Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-13
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0217
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0217
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-15
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-05
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-13
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-04-26
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-29
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.01
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-12-31
Earnings History > 7 > report Date
2021-03-29
Earnings History > 7 > date
2020-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.01
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-06-30
Earnings History > 8 > report Date
2020-09-16
Earnings History > 8 > date
2020-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-04-01
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.02
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-06-30
Earnings History > 10 > report Date
2019-09-11
Earnings History > 10 > date
2019-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.02
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.02
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-03-31
Earnings History > 11 > report Date
2019-04-10
Earnings History > 11 > date
2019-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.03
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.03
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-26
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.02
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-12-31
Earnings History > 13 > report Date
2018-03-21
Earnings History > 13 > date
2017-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.02
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.02
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-06-30
Earnings History > 14 > report Date
2017-09-12
Earnings History > 14 > date
2017-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.01
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-12-31
Earnings History > 15 > report Date
2017-03-23
Earnings History > 15 > date
2016-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.02
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2016-06-30
Earnings History > 16 > report Date
2016-09-13
Earnings History > 16 > date
2016-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.02
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.02
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2016-03-31
Earnings History > 17 > report Date
2016-04-21
Earnings History > 17 > date
2016-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.03
Earnings History > 17 > eps Estimate
-1.59
Earnings History > 17 > eps Difference
1.56
Earnings History > 17 > surprise Percent
98.1132
Earnings History > 18 > period
2014-06-30
Earnings History > 18 > report Date
2014-09-15
Earnings History > 18 > date
2014-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2013-12-31
Earnings History > 19 > report Date
2014-03-28
Earnings History > 19 > date
2013-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Stock Price
GBp 0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFutura Medical plc Advances Healthcare Innovation Within FTSE AIM Framework - Kalkine Media
1/12/2026
Futura Medical plc Advances Healthcare Innovation Within FTSE AIM Framework Kalkine Media
Read more →Spreadex reduces stake in Futura Medical to 3.92% By Investing.com - Investing.com South Africa
1/7/2026
Spreadex reduces stake in Futura Medical to 3.92% By Investing.com Investing.com South Africa
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Futura Medical
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.0217
EPS Estimate
0
EPS Difference
-0.0217
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.